公开(公告)号：US20230293079A1

公开(公告)日：2023-09-21

申请号：US17921929

申请日：2021-04-27

Applicant: SHANGHAI MING ENTROPY PHARMACEUTICAL TECHNOLOGY CO., LTD

Inventor： Kang Chen ,  Qing Cao

IPC: A61B5/318 ,  A61B5/00 ,  G06F18/2415

CPC classification number: A61B5/318 ,  A61B5/7264 ,  A61B5/7282 ,  A61B5/743 ,  G06F18/2415

Abstract: The present application relates to a field of image processing and discloses an ECG image processing method, device, medium, and an electrocardiograph. The ECG image processing method of the present application includes: receiving the ECG image; extracting a feature map of the ECG image, and reducing the feature map to obtain an attention map; extracting a feature matrix from the feature map and the attention map using a bilinear attention pooling; obtaining an expression matrix using an adaptive weight learning and a weighted fusion of the feature matrix by a multi-headed self-attention processing; and classifying the ECG image with a plurality of labels. This application allows direct interpretation of ECG images without limiting to a use of conventional digital signals, while capturing subtle discrepancies in the ECG image for classifying ECG abnormalities with high noise immunity.

公开(公告)号：US11756688B2

公开(公告)日：2023-09-12

申请号：US17829351

申请日：2022-05-31

Applicant: Tempus Labs, Inc. ,  Geisinger Clinic

Inventor： Alvaro E. Ulloa-Cerna ,  Noah Zimmerman ,  Greg Lee ,  Christopher M. Haggerty ,  Brandon K. Fornwalt ,  Ruijun Chen ,  John Pfeifer ,  Christopher Good

IPC: G16H50/30 ,  G16H50/20 ,  A61B5/318 ,  A61B5/00 ,  A61B5/28 ,  G06F18/214

CPC classification number: G16H50/30 ,  A61B5/0006 ,  A61B5/28 ,  A61B5/318 ,  A61B5/7275 ,  G16H50/20 ,  G06F18/2155

Abstract: A method for determining cardiology disease risk from electrocardiogram trace data and clinical data includes receiving electrocardiogram trace data associated with a patient, receiving the patient's clinical data, providing both sets of data to a trained machine learning composite model that is trained to evaluate the data with respect to each disease of a set of cardiology diseases including three or more of cardiac amyloidosis, aortic stenosis, aortic regurgitation, mitral stenosis, mitral regurgitation, tricuspid regurgitation, abnormal reduced ejection fraction, or abnormal interventricular septal thickness, generating, by the model and based on the evaluation, a composite risk score reflecting a likelihood of the patient being diagnosed with one or more of the cardiology diseases within a predetermined period of time from when the electrocardiogram trace data was generated, and outputting the composite risk score to at least one of a memory or a display.

公开(公告)号：US11744471B2

公开(公告)日：2023-09-05

申请号：US17444254

申请日：2021-08-02

Applicant: Masimo Corporation

Inventor： Massi Joe E. Kiani ,  Michael O'Reilly

IPC: A61B5/0205 ,  A61B5/00 ,  A61B5/318 ,  A61B5/369 ,  A61B5/1455 ,  A61B5/021 ,  A61B5/024 ,  A61B5/08 ,  A61B5/087

CPC classification number: A61B5/0205 ,  A61B5/1455 ,  A61B5/318 ,  A61B5/369 ,  A61B5/4821 ,  A61B5/4839 ,  A61B5/7278 ,  A61B5/7282 ,  A61B5/743 ,  A61B5/021 ,  A61B5/024 ,  A61B5/087 ,  A61B5/0816

Abstract: A non-invasive, optical-based physiological monitoring system is disclosed. In an embodiment, the non-invasive, optical-based physiological monitoring system comprises an emitter configured to emit light into a tissue site of a living patient; a detector configured to detect the emitted light after attenuation by the tissue site and output a sensor signal responsive to the detected light; and a processor configured to determine, based on the sensor signal, a first physiological parameter indicative of a level of pain of the patient.

公开(公告)号：US11737699B2

公开(公告)日：2023-08-29

申请号：US17719866

申请日：2022-04-13

Applicant: BioSig Technologies, Inc. ,  Mayo Foundation for Medical Education and Research

Inventor： Budimir S. Drakulic ,  Sina Fakhar ,  Thomas G. Foxall ,  Branislav Vlajinic ,  Samuel J. Asirvatham

IPC: A61B5/30 ,  A61B5/00 ,  A61B5/0245 ,  A61B5/318 ,  A61B5/308 ,  H04L43/02 ,  H04L47/50 ,  G16H40/63 ,  A61B18/00 ,  H02H9/04 ,  H03F3/45 ,  H03F3/68 ,  H03K5/125 ,  A61B5/0215 ,  A61B5/024 ,  A61B5/0538 ,  A61B18/14 ,  A61B5/361 ,  A61B5/363 ,  A61B5/352 ,  A61B5/366

CPC classification number: A61B5/30 ,  A61B5/0245 ,  A61B5/308 ,  A61B5/318 ,  A61B5/7203 ,  A61B5/7225 ,  A61B5/7246 ,  A61B5/0006 ,  A61B5/0215 ,  A61B5/02405 ,  A61B5/0538 ,  A61B5/352 ,  A61B5/361 ,  A61B5/363 ,  A61B5/366 ,  A61B5/4836 ,  A61B5/7217 ,  A61B5/742 ,  A61B5/7435 ,  A61B18/1492 ,  A61B2018/00351 ,  A61B2018/00577 ,  A61B2562/18 ,  A61B2562/223 ,  G16H40/63 ,  H01L2924/14335 ,  H02H9/04 ,  H02H9/045 ,  H03F3/45 ,  H03F3/45475 ,  H03F3/68 ,  H03F2200/129 ,  H03F2200/171 ,  H03F2200/234 ,  H03F2200/375 ,  H03F2200/451 ,  H03F2203/45116 ,  H03F2203/45528 ,  H03F2203/45601 ,  H03K5/125 ,  H04L43/02 ,  H04L47/50 ,  H03H2017/0298 ,  H04B1/0014 ,  H04B1/0039

Abstract: Systems, methods, and computer program product embodiments are disclosed for performing electrophysiology (EP) signal processing. An embodiment includes an electrocardiogram (ECG) circuit board configured to process an ECG signal. The embodiment further includes a plurality of intracardiac (IC) circuit boards, each configured to process a corresponding IC signal. The ECG circuit board and the plurality of IC circuit boards share substantially a same circuit configuration and components. The ECG circuit board further processes the ECG signal using substantially a same path as each IC circuit board uses to process its corresponding IC signal.

公开(公告)号：US20230263402A1

公开(公告)日：2023-08-24

申请号：US17847417

申请日：2022-06-23

Applicant: Giant Power Technology Biomedical Corp. ,  National Taipei University of Technology

Inventor： CHIEN-JEN WANG ,  Po-En Liu ,  Shu-Hung Chao ,  Ming-Kun Huang ,  Ing-Lan Liou ,  Chun- Young Chang ,  Chin-Kun Tseng ,  Zi-Yi Zhuang ,  Ya-Wen Chao ,  Hsuan-Yu Liu ,  Gu-Neng Wu ,  Chun-Ling Lin ,  Yuh-Shyan Hwang ,  San-Fu Wang ,  I-Chyn Wey ,  Jason King

IPC: A61B5/02 ,  A61B5/024 ,  A61B5/318 ,  A61B5/00

CPC classification number: A61B5/02028 ,  A61B5/02427 ,  A61B5/318 ,  A61B5/725 ,  A61B5/7275 ,  A61B5/742

Abstract: A method for detecting a particular syndrome based on hemodynamic analysis that includes steps of: obtaining a piece of hemodynamic data representing a hemodynamic waveform; performing moving average (MA) filtering on the hemodynamic waveform to obtain a filtered waveform; determining troughs in order to determine waveform segments of the filtered waveform; determining smoothness of the waveform segments; and determining a relation between the hemodynamic waveform and a particular syndrome based on the smoothness of the waveform segments, and generating a detection result.

公开(公告)号：US11730376B2

公开(公告)日：2023-08-22

申请号：US16896976

申请日：2020-06-09

Applicant: California Institute of Technology

Inventor： Morteza Gharib ,  Niema M. Pahlevan

IPC: A61B5/02 ,  A61B5/00 ,  A61B5/021 ,  A61B5/022 ,  A61B5/0285 ,  A61B7/00 ,  A61B5/318

CPC classification number: A61B5/02028 ,  A61B5/0006 ,  A61B5/021 ,  A61B5/0285 ,  A61B5/02233 ,  A61B5/318 ,  A61B7/00

Abstract: A non-invasive and convenient method and apparatus for approximation of left ventricular end diastolic pressure (LVEDP) can be used in both hospital/clinic environments and nursing home or home environments. The method and apparatus use non-invasive sensors and a new “cardiac triangle” computational method to obtain an approximation of LVEDP. The computational method uses hemodynamic and electrocardiogram (ECG) waveforms as input, which can be collected by a portable device or devices.

公开(公告)号：US11712219B2

公开(公告)日：2023-08-01

申请号：US16713237

申请日：2019-12-13

Applicant: CANON MEDICAL SYSTEMS CORPORATION

Inventor： Yasuhiko Abe

IPC: A61B8/08 ,  A61B8/00 ,  A61B5/318

CPC classification number: A61B8/0883 ,  A61B8/4416 ,  A61B8/461 ,  A61B8/5223 ,  A61B5/318

Abstract: An ultrasonic wave diagnostic apparatus according to an embodiment includes processing circuitry. The processing circuitry acquires a plurality of pieces of volume data obtained through image capturing of a region including the cardiac ventricle of a subject for a predetermined duration. The processing circuitry estimates motion of tissue of the cardiac ventricle by using the pieces of volume data. The processing circuitry calculates, based on a result of the estimation, cardiac ventricle information indicating at least one of wall motion information and volume information related to the cardiac ventricle. The processing circuitry calculates, based on a result of the estimation, annulus information related to the size or shape of an annulus position of a valve related to inflow or outflow of blood current at the cardiac ventricle. The processing circuitry outputs the cardiac ventricle information and the annulus information.

公开(公告)号：US11712168B2

公开(公告)日：2023-08-01

申请号：US17456644

申请日：2021-11-29

Applicant: VITA-COURSE TECHNOLOGIES (HAINAN) CO., LTD.

Inventor： Ying Lu ,  Chuanmin Wei ,  Heng Peng ,  Jiwei Zhao ,  Ziming Deng ,  Zijian Huang

IPC: A61B5/02 ,  A61B5/024 ,  A61B5/00 ,  A61B5/021 ,  A61B5/318 ,  A61B5/0225 ,  A61B5/0245 ,  A61B5/11 ,  A61B5/145 ,  A61B5/1455 ,  G06F21/31 ,  A61B5/352 ,  A61B5/026 ,  A61B5/0205 ,  A61B5/01

CPC classification number: A61B5/02416 ,  A61B5/0225 ,  A61B5/0245 ,  A61B5/02125 ,  A61B5/02141 ,  A61B5/02255 ,  A61B5/1102 ,  A61B5/14542 ,  A61B5/14551 ,  A61B5/318 ,  A61B5/7203 ,  A61B5/7235 ,  A61B5/746 ,  G06F21/31 ,  A61B5/01 ,  A61B5/021 ,  A61B5/0205 ,  A61B5/026 ,  A61B5/352 ,  A61B2560/0228

Abstract: The present disclosure relates to a device, method and system for calculating, estimating, or monitoring the blood pressure of a subject based on physiological features and personalized models. At least one processor, when executing instructions, may perform one or more of the following operations. A first signal representing a pulse wave relating to heart activity of a subject may be received. A plurality of second signals representing time-varying information on a pulse wave of the subject may be received. A personalized model for the subject may be designated. Effective physiological features of the subject based on the plurality of second signals may be determined. A blood pressure of the subject based on the effective physiological features and the designated model for the subject may be calculated.

公开(公告)号：US11707227B2

公开(公告)日：2023-07-25

申请号：US15863722

申请日：2018-01-05

Applicant: Respirix, Inc.

Inventor： Evan S. Luxon ,  Daniel R. Burnett ,  Alexander Vergara ,  Mark Ziegler ,  Nikhil Viswanathan ,  Michael Hemati

IPC: A61B5/00 ,  A61B5/087 ,  A61B5/03 ,  A61B5/08 ,  A61B5/352 ,  A61B5/0205 ,  A61B5/024 ,  A61B5/0245 ,  A61B5/097 ,  A61M16/06 ,  A61M16/00 ,  G09B19/00 ,  A61B5/318 ,  A61B5/349 ,  A61B5/145 ,  A61B5/1455

CPC classification number: A61B5/682 ,  A61B5/0205 ,  A61B5/0245 ,  A61B5/02416 ,  A61B5/03 ,  A61B5/0803 ,  A61B5/087 ,  A61B5/097 ,  A61B5/352 ,  A61B5/4884 ,  A61B5/6826 ,  A61B5/14507 ,  A61B5/14551 ,  A61B5/318 ,  A61B5/349 ,  A61B2562/0247 ,  A61M16/00 ,  A61M16/06 ,  A61M2205/3569 ,  A61M2205/3592 ,  A61M2230/04 ,  A61M2230/40 ,  G09B19/003

Abstract: Devices and methods for monitoring physiologic parameters are described where an airway device, in one embodiment, may comprise a mouthpiece section and an opening section defining one or more airway lumens therethrough with a first sensor in fluid communication with the one or more airway lumens and a second sensor positioned upon a hand-piece for contact against a portion of the user. The first sensor may be configured to detect an airway pressure when a user inhales or exhales through the one or more airway lumens, and the second sensor may be configured to detect a physiological signal from the user. Additionally, a controller may be in communication with the first and second sensors where the controller is programmed to correlate pressure oscillations in the airway pressure with heartbeats.

公开(公告)号：US11701172B2

公开(公告)日：2023-07-18

申请号：US17219120

申请日：2021-03-31

Applicant: Mayo Foundation for Medical Education and Research

Inventor： Samuel J. Asirvatham ,  Mark B. Knudson

IPC: A61B18/18 ,  A61B18/14 ,  A61N1/20 ,  A61B5/0215 ,  A61B18/02 ,  A61M25/00 ,  A61M25/04 ,  A61M25/10 ,  A61N1/05 ,  A61B5/24 ,  A61B5/318 ,  A61B5/00 ,  A61N1/36 ,  A61B5/02 ,  A61B18/00 ,  A61N1/06

CPC classification number: A61B18/1492 ,  A61B5/0215 ,  A61B5/24 ,  A61B5/318 ,  A61B5/4035 ,  A61B18/02 ,  A61M25/007 ,  A61M25/04 ,  A61M25/10 ,  A61N1/0587 ,  A61N1/20 ,  A61N1/36114 ,  A61B5/02 ,  A61B2018/0022 ,  A61B2018/00083 ,  A61B2018/00214 ,  A61B2018/00351 ,  A61B2018/00434 ,  A61B2018/00577 ,  A61B2018/00839 ,  A61B2018/00994 ,  A61B2218/002 ,  A61M2025/105 ,  A61N1/06

Abstract: A method and device for modulating the autonomic nervous system adjacent a pericardial space to treat cardiac arrhythmia includes a treatment source arranged to supply a treatment medium, a catheter having an end sized for insertion into the pericardial space, a medium delivery assembly having a distal end arranged to be positioned by the catheter into the pericardium, with the distal end of the delivery assembly comprising a delivery tip arranged to extend away from the distal end of the catheter into the pericardial space. A connector operatively couples the delivery tip of the medium delivery assembly to the treatment source, and the delivery tip of the medium delivery assembly including a plurality of delivery points for delivering the treatment medium at a plurality of treatment areas within the pericardial space. The device performs modulation or ablation of the autonomic nervous system at selected treatment areas within the pericardium.